Immune checkpoint inhibitor induced large vessel vasculitis.

Daisy Henderson,Gelareh Eslamian,Daniel Poon,Simon J. Crabb,Robert Jones,Peter Sankey,Bihani Kularatne,Mark Linch,Debra H. Josephs

Immune checkpoint inhibitor induced large vessel vasculitis.

2020

Daisy Henderson
Gelareh Eslamian
Daniel Poon
Simon J. Crabb
Robert Jones
Peter Sankey
Bihani Kularatne
Mark Linch
Debra H. Josephs

This is a case report of a 67-year-old patient with castration resistant metastatic prostate cancer who developed an immune-mediated large vessel vasculitis following treatment with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1).

Keywords:

Oncology
Prostate cancer
Ipilimumab
Cancer Intervention
Internal medicine
Large vessel vasculitis
Nivolumab
Pathology
castration resistant
Vasculitis
Medicine
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations